Recherche
-
Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept.
(Pharmaceutics. vol. 15, n° 3, 2023-03-10)Article de revueLibre accès -
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueLibre accès -
Response to commentary "The importance of assessing left ventricular longitudinal function in presence of increased afterload".
(Critical Care. vol. 28, n° 1, pp. 103, 2024-03-29)Article de revueLibre accès -
First One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database.
(Archives of cardiovascular diseases. vol. 115, n° 2, pp. 78-86, 2022-02-01)Article de revueLibre accès -
Exacerbation of thrombo-inflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.
(Blood Advances, 2024-02-22)Article de revueLibre accès -
Early non-invasive ventilation and high-flow nasal oxygen therapy for preventing endotracheal intubation in hypoxemic blunt chest trauma patients: the OptiTHO randomized trial.
(Critical Care. vol. 27, n° 1, pp. 163, 2023-04-26)Article de revueLibre accès -
Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
(Experimental Hematology & Oncology. vol. 12, n° 1, pp. 50, 2023-05-30)Article de revueLibre accès -
Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study
(Critical Care. vol. 28, n° 1, pp. 54, 2024-02-20)Article de revueLibre accès -
The Normal and Brain Tumor Vasculature: Morphological and Functional Characteristics and Therapeutic Targeting.
(Frontiers in Physiology. vol. 12, pp. 622615, 2021-01-01)Article de revueLibre accès -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès